NetTargets and Cellkey sign MoU to collaborate on biomarker discovery

NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.

NetTargets will virtually present at Biotech showcase 2023.

NetTargets will deliver a virtual presentation at Biotech Showcase™ 2023, to be held on 09-11 January (Presentation Schedule : January 09 2023, 2:00 PM(PST)). It will also participate in the virtual partnering meeting on 18-19 January 2023.

01 Dec 2022

NetTargets and Daewoong Therapeutics signed MoU on anticancer drug research collaboration

NetTargets has partnered with Daewoong Therapeutics, for an anticancer drug research collaboration using NetTargets N-Map and N-Cap which are "AI-enhanced systems biology" based drug development platforms.

04 May 2022

NetTargets Inc. is introduced as one of the rising AI startup

The Korea Economic Daily introduced NetTargets Inc. as a rising AI startup, featuring its technology as the golden-egg goose.

02 Dec 2021

Comming soon

Our next news and events are coming soon

BACK TO THE LIST